Teleflex (NYSE: TFX) → Stocks, dividends, news, and other information


Free disabling of ads
Dividends News

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa (EMEA), Asia and Original Equipment Manufacturer and Development Services (OEM). The Vascular North America segment products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The Interventional North America segment is comprised of the North American component of Vascular Solutions business. The Anesthesia North America segment provides products for clinicians working primarily in emergency rooms, surgery and critical care settings. The Surgical North America segment products are predominantly comprised of single-use products, including ligation clips and closure products; appliers and sutures used in a variety of surgical procedures; access ports used in minimally invasive laparoscopic surgical procedures, including robotic surgery, and fluid management products used for chest drainage. The EMEA segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

  • TFX Symbol
  • NYSE Exchange
  • 15,200 Employees
2 rated
  • $361.80, +$0.17 (+0.05%) Previous Close
  • 228,089 Previous Volume
  • $221.27 / $409.27 52 week low / high
  • -11.60% Percent off 52 week high
  • 2020-10-20 Updated
  • 0.38% Dividend yield (trailing)
  • 0.38% Dividend yield (forward)
  • 46,338,774 Public float
  • 46,516,000 Outstanding shares
  • 34.92 P/E
  • 16.82 B Market Cap
Free disabling of ads

Financial statements

The information is not 100% up-to-date. There may be errors or something missing. Often something is missing, there are almost no errors, but I can't rule them out. Now I'm looking for a supplier of high-quality information, but so far what I find is expensive (about $ 2000 a year).
2015 2016 2017 2018 2019
Total Revenue 1.8B 1.9B 2.1B 2.4B 2.6B
Cost Of Revenue 860M 860M 970M 1.1B 1.1B
Gross Profit 940M 1B 1.2B 1.4B 1.5B
Research and Development 52M 59M 85M 110M 110M
Selling General and Admin 560M 560M 680M 820M 880M
Operating Expense 1.5B 1.5B 1.7B 2B 2.1B
Operating Income 330M 390M 410M 470M 500M
Other Income Expense Net -87M -140M -120M -250M -160M
EBIT 330M 390M 410M 470M 500M
Interest Income 61M 55M 83M 100M 80M
Pretax Income 240M 250M 280M 220M 340M
Income Tax 7.8M 8.1M 130M 23M -120M
Minority Interest 850K 460K 0 0 0
Net Income 240M 240M 150M 200M 460M
Net Income Basic 240M 240M 150M 200M 460M
2015 2016 2017 2018 2019
Current cash 340M 540M 330M 360M 300M
Short term investments
Receivables 260M 270M 350M 370M 420M
Inventory 330M 320M 400M 430M 480M
Other current assets 75M 51M 54M 85M 110M
Current assets 1B 1.2B 1.1B 1.2B 1.3B
Long term investments 150K 13M
Property plant equipment 320M 300M 380M 430M 540M
Goodwill 1.3B 1.3B 2.2B 2.2B 2.2B
Intangible assets 1.2B 1.1B 2.4B 2.3B 2.2B
Other assets 50M 32M 43M 32M 35M
Total assets 3.9B 3.9B 6.2B 6.3B 6.3B
Accounts payable 66M 69M 92M 110M 100M
Current long term debt 420M 180M 87M 87M 50M
Other current liabilities 170M 170M 290M 380M 400M
Total current liabilities 670M 430M 480M 580M 560M
Long term debt 650M 850M 2.2B 2.1B 2B
Other liabilities 49M 52M 370M 370M 200M
Minority Interest 850K 460K 0 0 0
Total Liabilities 1.9B 1.8B 3.8B 3.7B 3.3B
Common stock 42M 44M 45M 46M 48M
Retained earning 2B 2.2B 2.3B 2.4B 2.8B
Treasury stock 120K 140K 170K 160K 180K
Capital surplus 440M 510M 590M 570M 620M
Shareholder equity 2B 2.1B 2.4B 2.5B 3B
Net tangible assets -2.5B -2B -5B -5B -4.5B
2015 2016 2017 2018 2019
Net Income 240M 240M 150M 200M 460M
Depreciation 110M 120M 160M 210M 210M
Changes in receivables -9.6M -74M -20M -52M
Changes in inventories -8.4M 6.4M -22M -37M -53M
Cash change 35M 210M -210M 24M -56M
Cash flow 300M 410M 420M 440M 440M
Capital expenditures -61M -53M -71M -81M -100M
Investing activity other
Total investing cash flows -150M -66M -1.8B -200M -71M
Dividends paid -57M -59M -61M -62M -63M
Net borrowings -16M -43M 1.2B -94M -250M
Other financing cash flows -13M -7.6M -21M -51M -120M
Cash flow financing -86M -110M 1.1B -210M -420M
Exchange rate effect -25M -27M 61M -11M -3.3M
Free disabling of ads
Free disabling of ads